Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients

Journal of Pediatric Hematology/Oncology

Volumn 18, Issue 1, 1996, Pages 46-50

  Adams, Denise M ^a   Schultz, William H ^a   Ware, Russell E ^a   Kinney, Thomas R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Erythrocytapheresis; Erythrocyte transfusions; Iron chelation; Sickle cell anemia

Indexed keywords

DEFEROXAMINE; FERRITIN;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ARTICLE; CHELATION THERAPY; CHILD; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; CYTAPHERESIS; DRUG COST; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; IRON OVERLOAD; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; ANEMIA, SICKLE CELL; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; CYTAPHERESIS; DEFEROXAMINE; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITINS; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 0030040223     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199602000-00009     Document Type: Article

References (19)

1. Powars D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med 1978;65:461-71.
2. Piomelli S. Sickle cell diseases in the 1990's: the need for active and preventive intervention. Semin Hematol 1991;28:227-32.
3. Wayne A, Kevy S, Nathan D. Transfusion management of sickle cell disease. Blood 1993;81:1109-23.
4. Wang W, Kovnar E, Tonkin I, et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991;118:377-82.
5. Cohen A, Martin M, Silber J, et al. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992;79:1657-61.
6. Cohen A. Management of iron overload in the pediatric patient. Hematol Oncol Clin North Am 1987;3:521-42.
7. Olivieri NF, Buncic JR, Chew E, et al. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med 1986;314:869-73.
8. Olivieri NF, Koren G, Hermann C, et al. Comparison of oral chelator L1 and desferrioxamine in iron-loaded patients. Lancet 1990;336:1275-9.
9. Brittenham G, Griffith P, Nienhuis A, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73.
10. Klein HG, Garner RJ, Miller DM, et al. Automated partial exchange transfusion in sickle cell anemia. Transfusion 1980;20:578-84.
11. Castro O, Finke-Castro H, Coats D. Improved method for automated red cell exchange in sickle cell disease. J Clin Apheresis 1986;3:93-8.
12. Cohen AR, Kim HC, Martin M, et al. Prevention of iron overload by erythrocytapheresis after stroke in sickle cell disease [Abstract]. Presented at the National Sickle Cell Centers Meeting, March 1995.
13. Kim H, Dugan N, Silber J, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994;83:1136-42.
14. Simondsen R, Sebek L, Moste J, et al. Microparticle enzyme immunoassays for creatine kinase MB and ferritin on the Abbott AxSYM system. Clin Chem 1993;39:1979-82.
15. Agarwan MB, Gupte SS, Viswanathan C, et al. Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion-dependent thalassaemia: Indian trial. Br J Haematol 1992;82:460-6.
16. Al-Refaie FN, Wonke B, Hoffbrand AV, et al. Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood 1992;80:592-9.
17. Olivieri NF, Matsui D, Koren G, et al. Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia. Blood 1992; 79:2741-8.
18. Vichinsky EP, Earles A, Johnson RA, Hoag MS, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-21.
19. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease Blood 1990;76:1431-7.